|
1
|
Arvanitakis Z, Wilson RS, Bienias JL,
Evans DA and Bennett DA: Diabetes mellitus and risk of Alzheimer
disease and decline in cognitive function. Arch Neurol. 61:661–666.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Engelgau MM, Geiss LS, Saaddine JB, et al:
The evolving diabetes burden in the United States. Ann Intern Med.
140:945–950. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van den Berg E, Reijmer YD, de Bresser J,
et al: Utrecht Diabetic Encephalopathy Study Group: A 4 year
follow-up study of cognitive functioning in patients with type 2
diabetes mellitus. Diabetologia. 53:58–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huber JD: Diabetes, cognitive function,
and the blood-brain barrier. Curr Pharm Des. 14:1594–1600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Strachan MW, Price JF and Frier BM:
Diabetes, cognitive impairment, and dementia. BMJ. 336:62008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peila R, Rodriguez BL and Launer LJ:
Honolulu-Asia Aging Study: Type 2 diabetes, APOE gene and the risk
for dementia and related pathologies: The Honolulu-Asia Aging
Study. Diabetes. 51:1256–1262. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Breteler MM: Vascular risk factors for
Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging.
21:153–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gispen WH and Biessels GJ: Cognition and
synaptic plasticity in diabetes mellitus. Trends Neurosci.
23:542–549. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Anarkooli Jafari I, Sankian M, Ahmadpour
S, Varasteh AR and Haghir H: Evaluation of Bcl-2 family gene
expression and Caspase-3 activity in hippocampus STZ-induced
diabetic rats. Exp Diabetes Res. 2008:6384672008.PubMed/NCBI
|
|
10
|
Revsin Y, Rekers NV, Louwe MC, et al:
Glucocorticoid receptor blockade normalizes hippocampal alterations
and cognitive impairment in streptozotocin-induced type 1 diabetes
mice. Neuropsychopharmacology. 34:747–758. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang C, Zhu B, Ding J and Wang ZG:
Isoflurane anesthesia aggravates cognitive impairment in
streptozotocin-induced diabetic rats. Int J Clin Exp Med.
7:903–910. 2014.PubMed/NCBI
|
|
12
|
Denver RJ, Bonett RM and Boorse GC:
Evolution of leptin structure and function. Neuroendocrinology.
94:21–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh A, Wirtz M, Parker N, et al:
Leptin-mediated changes in hepatic mitochondrial metabolism,
structure and protein levels. Proc Natl Acad Sci USA.
106:13100–13105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harvey J, Shanley LJ, O'Malley D and
Irving AJ: Leptin: A potential cognitive enhancer? Biochem Soc
Trans. 33:1029–1032. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Minokoshi Y, Kim YB, Peroni OD, et al:
Leptin stimulates fatty-acid oxidation by activating AMP-activated
protein kinase. Nature. 415:339–343. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Minokoshi Y and Kahn BB: Role of
AMP-activated protein kinase in leptin-induced fatty acid oxidation
in muscle. Biochem Soc Trans. 31:196–201. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi X, Cao S, Chang B, et al: Effects of
acute exercise and chronic exercise on the liver leptin-AMPK-ACC
signaling pathway in rats with type 2 diabetes. J Diabetes Res.
2013:9464322013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Namkoong C, Kim MS, Jang PG, et al:
Enhanced hypothalamic AMP-activated protein kinase activity
contributes to hyperphagia in diabetic rats. Diabetes. 54:63–68.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sharma B and Singh N: Attenuation of
vascular dementia by sodium butyrate in streptozotocin diabetic
rats. Psychopharmacology (Berl). 215:677–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu X, Raina AK, Lee HG, Casadesus G,
Smith MA and Perry G: Oxidative stress signalling in Alzheimer's
disease. Brain Res. 1000:32–39. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davis C, Mudd J and Hawkins M:
Neuroprotective effects of leptin in the context of obesity and
metabolic disorders. Neurobiol Dis. 72:61–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salminen A, Kaarniranta K, Haapasalo A,
Soininen H and Hiltunen M: AMP-activated protein kinase: A
potential player in Alzheimer's disease. J Neurochem. 118:460–474.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai Z, Yan LJ, Li K, Quazi SH and Zhao B:
Roles of AMP-activated protein kinase in Alzheimer's disease.
Neuromolecular Med. 14:1–14. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greco SJ, Sarkar S, Johnston JM and
Tezapsidis N: Leptin regulates tau phosphorylation and amyloid
through AMPK in neuronal cells. Biochem Biophys Res Commun.
380:98–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Greco SJ, Hamzelou A, Johnston JM, Smith
MA, Ashford JW and Tezapsidis N: Leptin boosts cellular metabolism
by activating AMPK and the sirtuins to reduce tau phosphorylation
and β-amyloid in neurons. Biochem Biophys Res Commun. 414:170–174.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Praticò D, Clark CM, Liun F, Rokach J, Lee
VY and Trojanowski JQ: Increase of brain oxidative stress in mild
cognitive impairment: a possible predictor of Alzheimer disease.
Arch Neurol. 59:972–976. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fukui K, Omoi NO, Hayasaka T, et al:
Cognitive impairment of rats caused by oxidative stress and aging
and its prevention by vitamin E. Ann NY Acad Sci. 959:275–284.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Padurariu M, Ciobica A, Hritcu L, Stoica
B, Bild W and Stefanescu C: Changes of some oxidative stress
markers in the serum of patients with mild cognitive impairment and
Alzheimer's disease. Neurosci Lett. 469:6–10. 2010. View Article : Google Scholar : PubMed/NCBI
|
